US Stock MarketDetailed Quotes
SAM Boston Beer
- 290.910
- +20.390+7.54%
Close Jul 26 16:00 ET
- 290.910
- 0.0000.00%
Post 20:01 ET
3.41BMarket Cap38.08P/E (TTM)
295.095High262.000Low358.74KVolume262.000Open270.520Pre Close103.01MTurnover4.01%Turnover Ratio46.85P/E (Static)11.72MShares395.52052wk High3.28P/B2.61BFloat Cap254.40052wk Low--Dividend TTM8.96MShs Float1349.980Historical High--Div YieldTTM12.23%Amplitude6.500Historical Low287.136Avg Price1Lot Size
Boston Beer Stock Forum
Sign in to post a comment
$DexCom(DXCM.US$ — Shares of the medical device company plunged more than 35%. Dexcom’s fiscal full-year revenue guidance of $4 billion to $4.05 billion marked a reduction from the outlook it shared earlier in the year. Revenue in the second quarter missed analysts’ expectations, coming in at $1 billion versus consensus estimates of $1.04 billion, per LSEG. Insulet shares slipped 9.1% in sympathy.
$Boston Beer(SAM.US$ –...
$Boston Beer(SAM.US$ –...
1
Boston Beer Company's revenue growth is expected to slow down substantially, underperforming the wider industry. Despite this, the consensus price target remains unchanged, suggesting that the downgrades are not expected to have a long-term impact on the company's valuation.
2
RECAP
The artificial intelligence mania that fueled the stock market to record highs this year was taking a breather Wednesday. Shares of chip makers were among those posting declines. $NVIDIA(NVDA.US$ shares were roughly flat.
Stock indexes fell. The $S&P 500 Index(.SPX.US$ fell 0.17%, while the $Nasdaq Composite Index(.IXIC.US$ fell 0.55% and $Dow Jones Industrial Average(.DJI.US$ fell 0.06%.
Benchmark $U.S. 10-Year Treasury Notes Yield(US10Y.BD$ fell belo...
The artificial intelligence mania that fueled the stock market to record highs this year was taking a breather Wednesday. Shares of chip makers were among those posting declines. $NVIDIA(NVDA.US$ shares were roughly flat.
Stock indexes fell. The $S&P 500 Index(.SPX.US$ fell 0.17%, while the $Nasdaq Composite Index(.IXIC.US$ fell 0.55% and $Dow Jones Industrial Average(.DJI.US$ fell 0.06%.
Benchmark $U.S. 10-Year Treasury Notes Yield(US10Y.BD$ fell belo...
26
1
CFRA's Garrett Nelson downgraded the company's stock to Sell, predicting a drop to $275 within a year. UBS's Peter Grom kept a Neutral rating but reduced his price target to $355 from $390, citing doubts about near-term sales growth.
Morning Movers
Gapping up
$Tesla(TSLA.US$ stock rose 0.3% after Chief Executive Elon Musk said the electric vehicle manufacturer had completed production design on a long-planned update to its Roadster electric sportscar, adding that it was likely to ship starting next year.
$TJX Companies(TJX.US$ stock rose 1.4% after the retailer topped market expectations for fourth-quarter sales on Wednesday as shoppers flocked to its T...
Gapping up
$Tesla(TSLA.US$ stock rose 0.3% after Chief Executive Elon Musk said the electric vehicle manufacturer had completed production design on a long-planned update to its Roadster electric sportscar, adding that it was likely to ship starting next year.
$TJX Companies(TJX.US$ stock rose 1.4% after the retailer topped market expectations for fourth-quarter sales on Wednesday as shoppers flocked to its T...
28
The stock seems overpriced compared to industry average. Despite its volatility and potential for price drop, the market has factored in the company's positive outlook. The stock's price surpasses its industry peers, suggesting it may not be the best time to buy.
Boston Beer Company's ROCE trend is disappointing, with diminishing returns despite business reinvestment. The stock's 5-year return to shareholders is only 30%, mirroring these poor trends. Investors seeking a multi-bagger might find better opportunities elsewhere.
Investors anticipate Boston Beer Company's sustained growth, justifying its high P/E ratio. The potential for earnings deterioration is not seen as significant enough to warrant a lower P/E ratio, providing strong share price support.
Constellation Brands had a weak quarter with underwhelming earnings guidance. Duckhorn showed the slowest revenue growth and weakest full-year guidance. Boston Beer and Zevia PBC had mixed quarters with misses and beats on various estimates.
Significant insider selling activities at Boston Beer Company over the last three months could be cause for investor concern. Despite the company's growth and profitability, the lack of insider purchases over the last year implies potential lack of confidence in the stock.
1
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
Lucky2828 : This is why peoples always take profit before earning result. There is no guarantee for the estimate revenue. Just ask yourself a question, if u brought the share at 50 dollars, now it rose to 100 dollars, will u take profit first? I hv saw some shares trading at 130 dollars before earning result. When it miss the estimate revenue, it dropped from 130 to 50 dollars. That's not the end, it continued to drop from 50 till 13 dollars for the next 3 days. There's no control at all.